Back to results
US 2015/0105393 A1Published application
Amide derivatives as ttx-s blockers
AssigneeRaQualia Pharma Inc.
InventorsTatsuya Yamagishi, Kiyoshi Kawamura, Mikio Morita
Life of this patent
Estimating the term…
Abstract
The present invention relates to amide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.
Claims15
A compound of the following formula (I):
- wherein:
- A is aryl;
- B is selected from the group consisting of a chemical bond, —CH═CH—, —C1-6 alkylene-, —C3-7 cycloalkylene-, —O—C1-6 alkylene-, —C1-6 alkylene-NR7—, —NR′—, and —C1-6 alkylene-O—;
- W is hydrogen, or C1-6 alkyl;
- Z is nitrogen atom or CH;
- R1 is fluorinated substituent;
- R2 is independently selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) hydroxyl, (4) —On—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (5) —On—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (6) —On—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R7, (7) —On-phenyl or —On-naphthyl, where the phenyl or naphthyl is unsubstituted or substituted with one or more substituents independently selected from R7, (8) —On-heterocyclic group, where the heterocyclic group is unsubstituted or substituted with one or more substituents independently selected from R7, (9) —(C═O)—NR8R9, (10) —NR8R9, (11) —S(O)2—NR8R9, (12) —NR8—S(O)2R9, (13) —S(O)t—R9, where t is 0, 1 or 2, (14) —NR8(C═O)R9, (15) —CN, and (16) —NO2;
- wherein n is 0 or 1;
- when n is 0, a chemical bond is present in the place of —On—;
- p is 1, 2, 3, or 4;
- when p is two or more than two, R2 may be same or different;
- R3 and R4 are independently hydrogen or C1-6 alkyl which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, and —O—C1-6 alkyl;
- or R3 form a 3 to 7 membered ring with R4 which may contain nitrogen atom, oxygen atom, sulfur atom or double bond, wherein the 3 to 7 membered ring is optionally substituted with 1 to 6 substituents independently selected from the group consisting of:
- (1) hydrogen, (2) hydroxyl, (3) halogen, (4) C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (5) C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (6) —O—C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, and (7) —O—C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10;
- R5 is independently selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) —On—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (4) On—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R7, and (5) —On—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R7;
- wherein n is 0 or 1;
- when n is 0, a chemical bond is present in the place of —On—;
- q is 1, 2 or 3;
- when q is two or more than two, R5 may be same or different;
- R6 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-7 cycloalkyl, or aryl, which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, C1-6 alkyl, —O—C1-6 alkyl, —C3-7 cycloalkyl, and —O—C3-7 cycloalkyl;
- R7 is selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) hydroxyl, (4) —(C═O)m—Ol—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R10, (5) —Ol—(C1-3)perfluoroalkyl, (6) —(C═O)m—Ol—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R10, (7) —(C═O)m—Ol—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R10, (8) —(C═O)m—Ol-phenyl or —(C═O)m—Ol-naphthyl, where the phenyl or naphthyl is unsubstituted or substituted with one or more substituents independently selected from R10, (9) —(C═O)m—Ol-heterocyclic group, where the heterocyclic group is unsubstituted or substituted with one or more substituents independently selected from R10, (10) —(C═O)—NR8R9, (11) —NR8R9, (12) —S(O)2—NR8R9, (13) —S(O)t—R8, where t is 0, 1 or 2, (14) —CO2H, (15) —CN, and (16) —NO2;
- wherein l is 0 or 1 and m is 0 or 1;
- when l is 0 or m is 0, a chemical bond is present in the place of —Ol— or —(C═O)m—, and when l is 0 and m is 0, a chemical bond is present in the place of —(C═O)m—Ol—;
- R8 and R9 are independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-7 cycloalkyl, or aryl, which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, C1-6 alkyl, —O—C1-6 alkyl, C3-7 cycloalkyl, and —O—C3-7 cycloalkyl;
- or R8 form a 4 to 7 membered ring with R9 which may contain nitrogen atom, oxygen atom, sulfur atom or double bond, wherein the 4 to 7 membered ring is optionally substituted with 1 to 6 substituents independently selected from the group consisting of:
- (1) hydrogen, (2) hydroxyl, (3) halogen, (4) C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (5) C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (6) —O—C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, and (7) —O—C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10;
- R1° is independently selected from the group consisting of:
- (1) hydrogen, (2) hydroxyl, (3) halogen, (4) —C1-6 alkyl, (5) —C3-6 cycloalkyl, (6) —O—C1-6 alkyl, (7) —O(C═O)—C1-6 alkyl, (8) —NH—C1-6 alkyl, (9) phenyl, (10) heterocyclic group, and (11) —CN;
- or a prodrug thereof or a pharmaceutically acceptable salt thereof.
29 more elements
A compound of the following formula (II)
- wherein:
- X is nitrogen atom, or CH;
- Y is nitrogen atom, or CH;
- Z is nitrogen atom, or CH;
- W is hydrogen, or C1-6 alkyl;
- R1 is fluorinated substituent independently selected from the group consisting of —CF3, —CHF2, —OCF3, —OCHF2, —OCH2CHF2, —OCH2CF3, —OCF2CHF2, —OCF2CF3, —OCH2CH2CF3, —OCH(CH3)CF3, —OCH2C(CH3)F2, —OCH2CF2CHF2, —OCH2CF2CF3, —OCH2CH2OCH2CF3, —NHCH2CF3, —SCF3, —SCH2CF3, —CH2CF3, —C(CH3)2CF3, —CH2CH2CF3, —CH2OCH2CF3, —OCH2CH2OCF3, 4,4-difluoropiperidino, and (4-fluorobenzyl)oxy;
- R2 is independently selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) hydroxyl, (4) —On—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (5) —On—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (6) —On—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R7, (7) —On-phenyl or —On-naphthyl, where the phenyl or naphthyl is unsubstituted or substituted with one or more substituents independently selected from R7, (8) —On-heterocyclic group, where the heterocyclic group is unsubstituted or substituted with one or more substituents independently selected from R7, (9) —(C═O)—NR8R9, (10) —NR8R9, (11) —S(O)2—NR8R9, (12) —NR8—S(O)2R9, (13) —S(O)2R9, where t is 0, 1 or 2, (14) —NR8(C═O)R9, (15) —CN, and (16) —NO2;
- wherein n is 0 or 1;
- when n is 0, a chemical bond is present in the place of —On—;
- p is 1, 2, 3, or 4;
- when p is two or more than two, R2 may be same or different;
- R3 and R4 are independently hydrogen or C1-6 alkyl which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, and —O—C1-6 alkyl;
- R5 is independently selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) —On—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R7, (4) —On—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R7, and (5) —On—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R7;
- wherein n is 0 or 1;
- when n is 0, a chemical bond is present in the place of —On—;
- q is 1, 2 or 3;
- when q is two or more than two, R5 may be same or different;
- R6 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-7 cycloalkyl, or aryl, which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, C1-6 alkyl, —O—C1-6 alkyl, —C3-7 cycloalkyl, and —O—C3-7 cycloalkyl;
- R7 is selected from the group consisting of:
- (1) hydrogen, (2) halogen, (3) hydroxyl, (4) —(C═O)m—Ol—C1-6 alkyl, where the alkyl is unsubstituted or substituted with one or more substituents independently selected from R10, (5) —Ol—(C1-3)perfluoroalkyl, (6) —(C═O)m—Ol—C3-6 cycloalkyl, where the cycloalkyl is unsubstituted or substituted with one or more substituents independently selected from R10, (7) —(C═O)m—Ol—C2-4 alkenyl, where the alkenyl is unsubstituted or substituted with one or more substituents independently selected from R10, (8) —(C═O)m—Ol-phenyl or —(C═O)m—Ol-naphthyl, where the phenyl or naphthyl is unsubstituted or substituted with one or more substituents independently selected from R10, (9) —(C═O)m—Ol-heterocyclic group, where the heterocyclic group is unsubstituted or substituted with one or more substituents independently selected from R10, (10) —(C═O)—NR8R9, (11) —NR8R9, (12) —S(O)2—NR8R9, (13) —S(O)t—R8, where t is 0, 1 or 2, (14) —CO2H, (15) —CN, and (16) —NO2;
- wherein l is 0 or 1 and m is 0 or 1;
- when l is 0 or m is 0, a chemical bond is present in the place of —Ol— or —(C═O)m—, and when l is 0 and m is 0, a chemical bond is present in the place of —(C═O)m—Ol;
- R8 and R9 are independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-7 cycloalkyl, or aryl, which is unsubstituted or substituted with one or more substituents independently selected from halogen, hydroxyl, C1-6 alkyl, —O—C1-6 alkyl, C3-7 cycloalkyl, and —O—C3-7 cycloalkyl;
- or R8 form a 4 to 7 membered ring with R9 which may contain nitrogen atom, oxygen atom, sulfur atom or double bond, wherein the 4 to 7 membered ring is optionally substituted with 1 to 6 substituents independently selected from the group consisting of:
- (1) hydrogen, (2) hydroxyl, (3) halogen, (4) C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (5) C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, (6) —O—C1-6 alkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10, and (7) —O—C3-6 cycloalkyl, which is unsubstituted or substituted with one or more substituents independently selected from R10;
- R10 is independently selected from the group consisting of:
- (1) hydrogen, (2) hydroxyl, (3) halogen, (4) —C1-6 alkyl, (5) —C3-6 cycloalkyl, (6) —O—C1-6 alkyl, (7) —O(C═O)—C1-6 alkyl, (8) —NH—C1-6 alkyl, (9) phenyl, (10) heterocyclic group, and (11) —CN;
- or a prodrug thereof or a pharmaceutically acceptable salt thereof.
27 more elements
Dependencies are inferred from the claim text.